How Vir Bio CEO Marianne De Backer Is Rebuilding Commercial Momentum

 
• By David Wild

From billion-dollar COVID antibody to a strategic reset, Marianne De Backer is navigating Vir's comeback through pipeline focus and disciplined leadership.

Marianne De Backer Has Guided Vir Biotechnology Through A Pipeline Pivot • Source: Shutterstock

More from C-Suite Speaks

More from Growth